Project Grant S10OD038289

Award Date 5/1/25
Completion Date 4/30/26
Dollars Obligated $594K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
The University of Texas at San Antonio received a $403,830 project grant award from the National Science Foundation Office of Integrative Activities under the Mathematical and Physical Sciences program (CFDA 47.049) to acquire a next-generation high-resolution mass spectrometer with ion mobility separation. The mass spectrometer will allow researchers to separate and analyze complex mixtures of biomolecules with unprecedented resolution from August 1, 2021 through July 31, 2022. The new...
The National Institute of General Medical Sciences (NIGMS) awarded a $719,476 Project Grant under CFDA 93.859, Biomedical Research and Research Training, to the University of California, Irvine. The funding will be used to acquire a state-of-the-art MALDI-QTOF mass spectrometer for imaging mass spectrometry (MALDI IMS) to support multiple NIH-funded programs at the university. The high-speed, high-resolution instrument will enable spatial phenotyping of biomolecules, including proteins,...
This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $1,089,778.00 to the University of Colorado Boulder (CU-Boulder) to acquire a high-resolution liquid chromatography-mass spectrometry system. The proposed instrument, a Waters Select Series Cyclic IMS QTOF mass spectrometer, will enable advanced small molecule and biomolecule analyses, including intact protein mass analysis, peptide mapping, and hydrogen-deuterium...
The National Institutes of Health (NIH) awarded a $635,689 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The University of Texas Health Science Center at San Antonio (UTHSCSA) to purchase a ZEISS LSM 980 Confocal Microscope with Airyscan 2. This advanced microscope will replace aging and inadequate confocal microscopes currently used by over 80 NIH-funded investigators at UTHSCSA's Optical Imaging Core Facility, which supports more than $60 million in annual...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $250,000 to Montana State University Billings (MSUB) to acquire an Agilent 1290 Infinity Series II Ultra-High-Performance Liquid Chromatography (UHPLC) system integrated with a 6530 Quadrupole Time-of-Flight (QTOF) mass spectrometer. This cutting-edge analytical instrument will enable MSUB to conduct advanced biomedical...
The National Institute of General Medical Sciences (NIGMS) awarded a $194,590 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Texas State University. The award will fund the acquisition of a Zeiss Axio Observer 7 wide-field fluorescence microscope with Apotome-3 and live-cell imaging capabilities. This new instrument will be housed in the university's Shared Resource Operations (SRO) and will directly strengthen the research programs of three...
This federal Project Grant award from the National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), provides $949,116 to the University of South Florida (USF) to acquire a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system. The instrument will establish a unique omics capability at USF to enable detailed, high-resolution structural analysis of low-level small molecules in complex biological matrices, with a focus...
The National Science Foundation (NSF) awarded a $636,312 Project Grant through its Integrative Activities program (CFDA 47.083) to the University of Southern Mississippi to acquire a state-of-the-art high-resolution liquid chromatography-mass spectrometer (LC-MS) system. This equipment will enhance the university's research, education, and outreach capabilities. The LC-MS instrument will allow graduate and undergraduate students to gain valuable skills in high-resolution mass spectrometry and...
The National Institutes of Health (NIH) awarded a $597,985 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to Baylor College of Medicine to acquire a QTRAP 7500 hybrid quadrupole-linear ion trap mass spectrometer and Shimadzu UHPLC system. This state-of-the-art liquid chromatography-mass spectrometry (LC-MS) platform will expand the Baylor College of Medicine's bioanalytical capacity to support increasing levels of pediatric translational research across multiple...
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a novel Orbitrap Astral mass spectrometer. This high-performance mass spectrometer will enable high-throughput, high-sensitivity proteomics research focused on advancing the understanding and treatment of cancer and Alzheimer's disease. The grant, awarded on...

The University of Texas Medical Branch at Galveston (UTMB) was awarded a $593,598 Project Grant through the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) to acquire a Waters Desorption Electrospray Ionization (DESI) XS XEVO TQ Absolute Mass Spectrometry Imaging (MSI) system. This specialized instrument will be used to support drug discovery and development research at UTMB's Sealy Institute for Drug Discovery, with applications in areas such as infectious disease, kidney disease, and neuroscience. The DESI XS TQ Absolute system provides enhanced metabolite detection and high spatial resolution imaging capabilities to visualize drugs, metabolites, and biomarkers within tissue samples, supporting projects aimed at identifying druggable targets, evaluating drug pharmacokinetics, and discovering new therapeutic biomarkers. This award will enable expanded access to MSI technology for UTMB investigators and facilitate new MSI-based research initiatives that leverage the analytical advantages of the DESI XS TQ Absolute system. The project period is from May 1, 2025 to April 30, 2026.

Generated 5/13/25, 3:22 AM